Clinical Trial Update: Study to Evaluate Safety and Efficacy of UB-421 Antibody in HIV-1 Infected Adults [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating the safety and efficacy of UB-421 antibody in HIV-1 infected adults has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• UB-421 (anti-CD4 antibody)

Snippet

Sponsor: United Biomedical | Conditions: HIV-1 Infection in Adults | Phase 2 | Status: COMPLETED